Nocturnal Leg Cramps and Prescription Use That Precedes Them A Sequence Symmetry Analysis

Background: The use of diuretics, statins, and inhaled long-acting beta 2-agonists (LABAs) is linked to muscle cramps but largely by anecdotal evidence. This study sought population-level data to better evaluate these associations. Methods: Linked health care databases containing prescribing information (December 1, 2000, to November 30, 2008) about 4.2 million residents of British Columbia, Canada, were evaluated using sequence symmetry analysis to determine in adults 50 years or older whether new quinine prescriptions (initiations of cramp treatment) increase in the year following diuretic, statin, or LABA starts. The statistic of interest was the sequence ratio: the number of quinine starts in the year following index drug introduction compared with the number of quinine starts in the preceding year (adjusted for age and time trends in population prescribing). Results: Adjusted sequence ratios (95% CIs) for the 3 drug classes were 1.47 (1.33-1.63 [P<.001]) for diuretics, 1.16 (1.04-1.29 [P=.004]) for statins, and 2.42 (2.02-2.89 [P<.001]) for LABAs. For diuretic subclasses, adjusted sequence ratios (95% CIs) were 2.12 (1.61-2.78 [P<.001]) for potassium sparing, 1.48 (1.29-1.68 [P<.001]) for thiazidelike, and 1.20 (1.00-1.44 [P=.07]) for loop. For LABA subclasses, adjusted sequence ratios (95% CIs) were 2.17 (1.56-3.02) for LABAs alone and 2.55 (2.06-3.12) for LABAs-corticosteroids (P<.001 for both). Conclusions: Cramp treatment was substantially more likely in the year following introduction of LABAs, potassium-sparing diuretics, or thiazidelike diuretics, and 60.3% of quinine users (individuals experiencing cramp) received at least 1 of these medications during a 13-year period. In contrast, statin and loop diuretic associations were small. Physicians should be mindful that the use of these medications may worsen symptoms in patients experiencing nocturnal leg cramps.